Fontana Andrea O, Gonzalez Melo Mary, Allenbach Gilles, Georgantas Costa, Wang Ruijia, Braissant Olivier, Barbey Frederic, Prior John O, Ballhausen Diana, Viertl David
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne CH-1011 Lausanne, Switzerland.
Paediatric Metabolic Unit, Pediatrics, Woman-Mother-Child Department, University of Lausanne and University Hospital of Lausanne Switzerland.
Am J Nucl Med Mol Imaging. 2021 Dec 15;11(6):519-528. eCollection 2021.
Evaluation of glomerular filtration rate is very important in both preclinical and clinical setting, especially in the context of chronic kidney disease. It is typically performed using Cr-EDTA or by imaging with I-Hippuran scintigraphy, which has a significantly lower resolution and sensitivity as compared to PET. Ga-EDTA represents a valid alternative due to its quick availability using a Ge/Ga generator, while PET/CT enables both imaging of renal function and accurate quantitation of clearance of activity from both plasma and urine. Therefore, we aimed at investigating the use of Ga-EDTA as a preclinical tracer for determining renal function in a knock-in rat model known to present progressive decline of renal function.
Ga-EDTA was injected in 23 rats, either wild type (n=10) or knock-in (n=13). By applying a unidirectional, two-compartment model and Rutland-Patlak Plot linear regression analysis, split renal function was determined from the age of 6 weeks to 12 months.
Glomerular filtration ranged from 0.025±0.01 ml/min at 6 weeks to 0.049±0.05 ml/min at 6 months in wild type rats. Glomerular filtration was significantly lower in knock-in rats at 6 and 12 months (P<0.01). No significant difference was observed in renal volumes between knock-in and wild type animals, based on imaging-derived volume calculations.
Ga-EDTA turned out to be a very promising PET/CT tracer for the evaluation of split renal function. This method allowed detection of progressive renal impairment in a knock-in rat model. Additional validation in a human cohort is warranted to further assess clinical utility in both, healthy individuals and patients with renal impairment.
肾小球滤过率的评估在临床前和临床环境中都非常重要,尤其是在慢性肾脏病的背景下。通常使用铬-乙二胺四乙酸(Cr-EDTA)或通过碘-马尿酸闪烁显像来进行评估,与正电子发射断层扫描(PET)相比,其分辨率和灵敏度显著较低。镓-乙二胺四乙酸(Ga-EDTA)由于可通过锗/镓发生器快速获得,是一种有效的替代方法,而PET/CT既能对肾功能进行成像,又能准确量化血浆和尿液中放射性活性的清除率。因此,我们旨在研究Ga-EDTA作为一种临床前示踪剂在已知肾功能呈进行性下降的基因敲入大鼠模型中用于确定肾功能的情况。
将Ga-EDTA注射到23只大鼠体内,其中野生型(n = 10)和基因敲入型(n = 13)。通过应用单向二室模型和鲁特兰-帕特拉克图线性回归分析,从6周龄到12月龄确定分肾功能。
野生型大鼠的肾小球滤过率在6周时为0.025±0.01毫升/分钟,在6个月时为0.049±0.05毫升/分钟。基因敲入型大鼠在6个月和12个月时的肾小球滤过率显著较低(P<0.01)。根据成像得出的体积计算,基因敲入型和野生型动物的肾体积没有显著差异。
Ga-EDTA被证明是一种非常有前景的用于评估分肾功能的PET/CT示踪剂。该方法能够检测基因敲入大鼠模型中的进行性肾功能损害。有必要在人类队列中进行进一步验证,以进一步评估其在健康个体和肾功能损害患者中的临床应用价值。